FindTrial
Sign In

Esmolol to treat tachicardia in septic shock - Esmolol in septic shock

Esmolol to treat tachicardia in septic shock - Esmolol in septic shock

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2010-023495-11-IT
Enrollment
Unknown
Registered
2011-02-02
Start date
2010-12-17
Completion date
Unknown
Last updated
2012-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

septic shock MedDRA version: 9.1 Level: LLT Classification code 10043071

Interventions

Pharmaceutical Form: Solution for infusion INN or Proposed INN: Esmolol Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 10-

Sponsors

AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: heart rate > 95 bpm in presence of septic shock Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: heart rate <95 bpm, age < 18 years

Design outcomes

Primary

MeasureTime frame
Main Objective: To maintain heart rate below a treshold of 95 bpm;Secondary Objective: Effects on systemic hemodynamic and organ functions;Primary end point(s): vasopressors requirements—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026